Corvus Pharmaceuticals (CRVS) EBIAT (2023 - 2025)
Historic EBIAT for Corvus Pharmaceuticals (CRVS) over the last 3 years, with Q3 2025 value amounting to -$10.2 million.
Historic EBIAT for Corvus Pharmaceuticals (CRVS) over the last 3 years, with Q3 2025 value amounting to -$10.2 million.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month